ArticleAndrology2026
Histopathological Characterization and Differential Expression of miRNAs in Male Pediatric Patients With Lichen Sclerosus.
Article in Andrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLichen sclerosus is a chronic, inflammatory, scarring disease of the skin that manifests mostly in the genital region.
objectiveWe studied the histomorphological characteristics, grade, and pattern of inflammation in male pediatric patients with lichen sclerosus. We also compared the expression of selected miRNAs in lichen sclerosus tissue, adjacent non-lichen sclerosus tissue from the same patient, and healthy male pediatric patients. RESULTS AND DISCUSSION: According to the type of inflammation/lymphocytic distribution, we categorized patients into four groups with the following features: (i) dominant lichenoid basal superficial inflammation, (ii) dominant band-like lymphocytic infiltration in the papillary sublayer of the dermis, (iii) mixed lymphocytic inflammation combining both patterns, and (iv) lymphocytic depletion with extensive fibrosis. The extent of inflammation was graded, with patients being categorized into weak, moderate, and strong inflammation groups. In terms of miRNA expression, hsa-miR-146a-5p, hsa-miR-146b-5p, hsa-miR-150-5p, and hsa-miR-155-5p were significantly upregulated, and hsa-miR-199b-5p and hsa-miR-200b-3p were significantly downregulated in lichen sclerosus tissue compared with adjacent normal tissue as well as normal tissue from male pediatric non-lichen sclerosus patients (p < 0.001). Hsa-miR-30b-5p was significantly downregulated in lichen sclerosus patients compared with male pediatric non-lichen sclerosus patients (p < 0.001). Pediatric male lichen sclerosus patients were categorized into two groups according to median age (≤9 years vs. >9 years); the early onset prepubertal patients presented, on average, a higher grade of inflammation (p = 0.020) and significantly higher miRNA hsa-miR-150-5p (p = 0.049) expression compared to the older group.
conclusionsHistopathological investigations can distinguish lichen sclerosus patient groups with different extents of disease. miRNAs could serve as candidate diagnostic markers for lichen sclerosus in pediatric male patients and may represent future therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.